Kanta Subbarao

Engineering H5N1 avian influenza viruses to study human adaptation, Taubenberger, J.K., Subbarao, K., Morens, D.M., Nature, 2012, 10.1038/nature11170

Human infections with avian influenza viruses., Subbarao, K., Joseph, T., Maryland medicine : MM : a publication of MEDCHI, the Maryland State Medical Society, 2005

Correction to "Severity of clinical disease and pathology in ferrets experimentally infected with influenza viruses is influenced by inoculum volume" [J Virol., 88, 23, (2014), 13879-13891], Subbarao, K., Qin, J., Kenney, H., Donahue, D., Paskel, M., Lamirande, E.W., Moore, I.N., Journal of Virology, 2016, 10.1128/JVI.02806-15

Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons, Subbarao, K., Cox, N.J., Klimov, A., Hall, H., Kunimoto, G.Y., Ueki, R.T., Normand, S., Li, Y., Xu, X., Shaw, M.W., Virology, 2002, 10.1006/viro.2002.1719

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection (The Journal of Experimental Medicine (2011) 208, 1, (181-193)), Wilson, P.C., Ahmed, R., Compans, R., Mulligan, M.J., Marasco, W.A., Subbarao, K., Yewdell, J.W., O'Donnell, C.D., Das, S.R., Wang, Y., Amara, R.R., Andrews, S., Kaur, K., Ali, Z., Huang, M., Lee, J.-H., Zheng, N.-Y., Del Rio, C., Razavi, B., Mehta, A., Lipkin, W.I., Hornig, M., Skountzou, I., McCausland, M., Morrissey, M., Sui, J., Edupuganti, S., Li, G.-M., Koutsonanos, D., Wrammert, J., Journal of Experimental Medicine, 2011, 10.1084/jem.201013522082c

Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection, Rose, J.K., Subbarao, K., Feldmann, H., Kobinger, G., Kobasa, D., Suguitan Jr., A., Roberts, A., Buonocore, L., Schwartz, J.A., Virology, 2007, 10.1016/j.virol.2007.04.021

Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms, Subbarao, K., Luke, C.J., Expert Review of Vaccines, 2014, 10.1586/14760584.2014.922416

Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies, Dimitrov, D.S., Jiang, S., Subbarao, K., Nabel, G.J., Curtis, K.M., Lanzavecchia, A., Baric, R., Wang, L.-F., Kim, J.-O., Feng, Y., Vogel, L., Corti, O., Sidorov, I.A., Rockx, B., Prabakaran, P., Hensley, L.E., Xiao, D., Sheahan, T., Roberts, A., He, Y., Chakraborti, S., Zhu, Z., Proceedings of the National Academy of Sciences of the United States of America, 2007, 10.1073/pnas.0701000104

Vesicular stomatitis virus-based H5N1 avian influenza vaccines induce potent cross-clade neutralizing antibodies in rhesus macaques, Rose, J.K., Subbarao, K., Marx, P.A., Hunter, M., Suguitan Jr., A., Buonocore, L., Schwartz, J.A., Journal of Virology, 2011, 10.1128/JVI.02491-10

Protective efficacy of influenza group 2 hemagglutinin stem-fragment immunogen vaccines, Kanta Subbarao, Raghavan Varadarajan, Ian N. Moore, Kevin W. Bock, Ketaki Ganti, Elaine W. Lamirande, Vamsee V. A. Mallajosyula, Saborni Chakraborty, Troy C. Sutton, npj Vaccines, 2017, 10.1038/s41541-017-0036-2

The contribution of animal models to the understanding of the host range and virulence of influenza A viruses, Subbarao, K., O'Donnell, C.D., Microbes and Infection, 2011, 10.1016/j.micinf.2011.01.014

Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice, Murphy, P.M., Murphy, B., Subbarao, K., Glass, W.G., Journal of Immunology, 2004

pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN, Nabel, G.J., Subbarao, K., Schwartz, O., Kong, W.-P., Leung, K., Ganesh, L., Huang, Y., Yang, Z.-Y., Journal of Virology, 2004, 10.1128/JVI.78.11.5642-5650.2004

SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism, Baric, R.S., Subbarao, K., Heise, M., Roberts, A., Lamirande, E.W., Ward, J.M., Funkhouser, W., Whitmore, A., Morrison, T.E., Chen, J., Frieman, M.B., PLoS Pathogens, 2010

Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters, Ambrosino, D.M., Subbarao, K., Zaki, S., Sullivan, J.L., Hayes, N., Vogel, L., Greenough, T.C., Babcock, G.J., Lamirande, E.W., Guarner, J., Thomas, W.D., Roberts, A., Journal of Infectious Diseases, 2006, 10.1086/500143

Avian influenza H6 viruses productively infect and cause illness in mice and ferrets, Subbarao, K., Kemble, G., Jin, H., Ye, D., Yang, C.-F., Aspelund, A., Chen, Z., Santos, C., Gillim-Ross, L., Journal of Virology, 2008, 10.1128/JVI.01206-08

Postexposure prophylaxis for measles in a neonatal intensive care unit, Kumar, M.L., Greenberg, J., Amin, S., Andrews-Mann, L., Subbarao, E.K., The Journal of Pediatrics, 1990, 10.1016/S0022-3476(05)83344-X

Rescue of an influenza A virus wild-type PB2 gene and a mutant derivative bearing a site-specific temperature-sensitive and attenuating mutation, Murphy, B.R., Kawaoka, Y., Subbarao, E.K., Journal of Virology, 1993

Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses, Bryant, M., Hietala, S., Woods, L., Yaying, J., Delia, M., Perdue, M.L., Subbarao, K., Klimov, A., Chongguang, L., Shengqiang, L., Journal of Infectious Diseases, 1999, 10.1086/314713

Generation and characterization of an H9N2 cold-adapted reassortant as a vaccine candidate, Subbarao, K., Murphy, B.R., Cox, N.J., Chen, Q., Matsuoka, Y., Chen, H., Avian Diseases, 2003

Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteers, Murphy, B.R., London, W.T., Karron, R.A., Fries, L.F., Subbarao, E.K., Clements, M.L., Journal of Clinical Microbiology, 1992

Influenza A virus infection complicated by fatal myocarditis, Zaki, S.R., Cox, N.J., Morken, T., Dawson, J.E., Shieh, W.-J., Guarner, J., Subbarao, K., Shaw, M.W., Oty, G., Alakija, P., Nolte, K.B., American Journal of Forensic Medicine and Pathology, 2000, 10.1097/00000433-200012000-00016

Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice, Subbaraoa, K., Wilson, P.C., Ahmed, R., Yewdell, J.W., Zheng, N.-Y., Mccausland, M., Li, G.-M., Wrammert, J., Das, S.R., Wright, A., Vogel, L., O'Donnell, C.D., mBio, 2012, 10.1128/mBio.00120-12

Comparison of a live attenuated 2009 H1N1 vaccine with seasonal influenza vaccines against 2009 pandemic H1N1 virus infection in mice and ferrets, Subbarao, K., Kemble, G., Jin, H., Santos, C., Lamirande, E.W., Min, J.-Y., Chen, G.L., Journal of Infectious Diseases, 2011, 10.1093/infdis/jiq144

Predicting the evolution of human influenza A, Fitch, W.M., Cox, N.J., Subbarao, K., Bender, C.A., Bush, R.M., Science, 1999, 10.1126/science.286.5446.1921

Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine, Subbarao, K., McCall, A.W., Lamirande, E.W., Lau, Y.-F., Chen, G.L., Proceedings of the National Academy of Sciences of the United States of America, 2011, 10.1073/pnas.1009908108

A 12-Month-Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response, Whitehead, S.S., Subbarao, K., Fraser, E.A., Walsh, M.C., Luke, C.J., Lovchik, J.M., Jo, M., Larsson, C.J., Sendra, E.A., McElvany, B.D., Sabundayo, B.P., Jarvis, A.P., Opert, K., Hynes, N., Grier, P.L., Tibery, C.M., Carmolli, M.P., Pierce, K.K., Kirkpatrick, B.D., Durbin, A.P., Journal of Infectious Diseases, 2016, 10.1093/infdis/jiw067

Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV, Taylor, D.R., Feinstone, S.M., Subbarao, K., Darnell, M.E.R., Journal of Virological Methods, 2004, 10.1016/j.jviromet.2004.06.006

Sequential Transmission of Influenza Viruses in Ferrets Does Not Enhance Infectivity and Does Not Predict Transmissibility in Humans, Kanta Subbarao, Sebastian Maurer-Stroh, Raphael T. C. Lee, Elodie Ghedin, Rita Czako, Devanshi R. Patel, Katherine E. E. Johnson, Elaine W. Lamirande, Troy C. Sutton, mBio, 2022, 10.1128/mbio.02540-22

Systems biology of vaccination for seasonal influenza in humans, Pulendran, B., Ahmed, R., Subbarao, K., Aderem, A., Mehta, A.K., Elbein, R., Li, S., Kokko, K.E., Kanchan, V., McCausland, M., Li, G.-M., Khan, N., Kasturi, S.P., Means, A.R., Haining, W.N., Marie-Kunze, S., Racioppi, L., Lee, E.K., Wrammert, J., Nakaya, H.I., Nature Immunology, 2011, 10.1038/ni.2067

Influenza vaccine-live, Subbarao, K., Lakdawala, S.S., Luke, C.J., Vaccines: Sixth Edition, 2012, 10.1016/B978-1-4557-0090-5.00027-6

Avian-to-human transmission of H9N2 subtype influenza A viruses: Relationship between H9N2 and H5N1 human isolates, Hay, A., Cox, N., Webster, R., Shortridge, K., Krauss, S., Guan, Y., Subbarao, K., Klimov, A., Lim, W., Cameron, K., Gregory, V., Shaw, M., Lin, Y.P., Proceedings of the National Academy of Sciences of the United States of America, 2000

Roadblocks to translational challenges on viral pathogenesis, Suzich, J., Subbarao, K., Picker, L., Drosten, C., Deeks, S., Nature Medicine, 2013, 10.1038/nm.3050

As good as the real thing, Subbarao, K., Journal of Pediatrics, 2000

Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets, Golding, H., Subbarao, K., King, L.R., Manischewitz, J., Sallusto, F., Lanzavecchia, A., Simmons, C.P., Rivera, Y., Suguitan Jr., A.L., Khurana, S., PLoS Medicine, 2009, 10.1371/journal.pmed.1000049

The immunobiology of SARS, Subbarao, K., Chen, J., Annual Review of Immunology, 2007, 10.1146/annurev.immunol.25.022106.141706

Influenza vaccines: Challenges and solutions, Subbarao, K., Houser, K., Cell Host and Microbe, 2015, 10.1016/j.chom.2015.02.012

Comparison of different approaches to measuring influenza A virus-specific hemagglutination inhibition antibodies in the presence of serum inhibitors, Murphy, B.R., Clements, M.L., Ryan-Poirier, K., Kawaoka, Y., Subbarao, E.K., Journal of Clinical Microbiology, 1992

Scientific barriers to developing vaccines against avian influenza viruses, Joseph, T., Subbarao, K., Nature Reviews Immunology, 2007, 10.1038/nri2054

A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: A randomized, double-blind clinical trial, Whitehead, S.S., Subbarao, K., Murphy, B.R., Luke, C.J., Wanionek, K., Carmolli, M.P., Hynes, N.A., Talaat, K.R., Shaffer, D., Sabundayo, B.P., Tibery, C., Lindow, J.C., Larsson, C.J., Elwood, D., Pierce, K.K., Kirkpatrick, B.D., Durbin, A.P., Journal of Infectious Diseases, 2013, 10.1093/infdis/jis936

Role of the viral polymerase during adaptation of influenza A viruses to new hosts, Kanta Subbarao, Melanie Duncan, Brad Gilbertson, Current Opinion in Virology, 2023, 10.1016/j.coviro.2023.101363

Corrigendum to: "Receptor specificity does not affect replication or virulence of the 2009 pandemic H1N1 influenza virus in mice and ferrets" [Virology 446 (1-2) (2013) 349-356]doi: 10.1016/j.virol.2013.08.011, Sasisekharan, R., Subbarao, K., Paskel, M., Moore, I., Lamirande, E.W., Jayaraman, A., Shih, A.R., Lakdawala, S.S., Virology, 2015, 10.1016/j.virol.2015.11.010

Evaluation of novel influenza a viruses and their pandemic potential, Bridges, C.B., Subbarao, K., Pediatric Annals, 2000

Correlates of immunity to influenza as determined by challenge of children with live, attenuated influenza vaccine, Treanor, J.J., Subbarao, K., Luke, C.J., Haynes, B.C., Rosenberg-Hasson, Y., Jegaskanda, S., Connor, R.I., Wieland-Alter, W., Brown, E.P., Ackerman, M.E., Ilyushina, N.A., Hoen, A.G., Wright, P.F., Open Forum Infectious Diseases, 2016, 10.1093/ofid/ofw108

Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A/Vietnam/1203/2004 vaccine virus in ferrets, Kemble, G., Jin, H., Subbarao, K., Cheng, X., Suguitan Jr., A.L., Zhou, H., Lu, B., Wang, W., Journal of Virology, 2010, 10.1128/JVI.00221-10

Influenza Viruses, Fiore, A.E., Subbarao, K., Dawood, F.S., Principles and Practice of Pediatric Infectious Diseases: Fourth Edition, 2012, 10.1016/B978-1-4377-2702-9.00231-2

An influenza A virus containing influenza B virus 5′ and 3′ noncoding regions on the neuraminidase gene is attenuated in mice, Enami, M., Murphy, B.R., Palese, P., Subbarao, E.K., Muster, T., Proceedings of the National Academy of Sciences of the United States of America, 1991

Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), Subbarao, K., Zaki, S.R., Rose, J.K., Kapadia, S.U., Lamirande, E.W., Genrich, G.L., Paddock, C.D., Roberts, A., Vogel, L.N., Vaccine, 2007, 10.1016/j.vaccine.2006.11.055

An addition to treatment options for avian influenza A H5N1?, Subbarao, K., Baz, M., The Lancet Infectious Diseases, 2015, 10.1016/S1473-3099(15)70019-8

Influenza virus vaccines: Lessons from the 2009 H1N1 pandemic, Subbarao, K., Broadbent, A.J., Current Opinion in Virology, 2011, 10.1016/j.coviro.2011.08.002

A general overview of viral vaccine development, Murphy, B.R., Subbarao, E.K., Advances in Experimental Medicine and Biology, 1992

A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults, Subbarao, K., Murphy, B.R., Kemble, G., Jin, H., Coelingh, K., Joseph, T., Schappell, E., McAuliffe, J., Thumar, B., Luke, C., Callahan, K., Karron, R.A., Journal of Infectious Diseases, 2009, 10.1086/596558

Avian influenza viruses infecting humans, Katz, J., Subbarao, K., Cellular and Molecular Life Sciences, 2000

A simple restriction fragment length polymorphism-based strategy that can distinguish the internal genes of human H1N1, H3N2, and H5N1 influenza a viruses, Subbarao, K., Cooper, L.A., Journal of Clinical Microbiology, 2000

Influenza A Virus Assembly Intermediates Fuse in the Cytoplasm, Subbarao, K., Shroff, H., Altan-Bonnet, N., Fodor, E., Lamirande, E.W., Broadbent, A.J., Kabat, J., Wawrzusin, P., Wu, Y., Lakdawala, S.S., PLoS Pathogens, 2014, 10.1371/journal.ppat.1003971

Advances in Influenza Virus Research: A Personal Perspective, Kanta Subbarao, Viruses, 2018, 10.3390/v10120724

Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants, Marasco, W.A., Subbarao, K., Farzan, M., Wong, S.K., Murakami, A., Vogel, L., Matthews, L.J., Roberts, A., Li, W., Sui, J., Journal of Virology, 2005, 10.1128/JVI.79.10.5900-5906.2005

An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults, Subbarao, K., Kemble, G., Coelingh, K.L., Jin, H., Lamirande, E.W., Chen, G.L., McMahon, B.A., Thumar, B., Luke, C.J., Karron, R.A., Talaat, K.R., Vaccine, 2011, 10.1016/j.vaccine.2011.02.043

A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults, Subbarao, K., Kemble, G., Murphy, B.R., Coelingh, K.L., Jin, H., Lamirande, E.W., Chen, G.L., DiLorenzo, S.C., Luke, C.J., Callahan, K.A., Karron, R.A., Talaat, K.R., Vaccine, 2009, 10.1016/j.vaccine.2009.03.082

Mammalian adaptation in the PB2 gene of avian H5N1 influenza virus, Subbarao, K., Ghedin, E., DePasse, J.V., Toyoda, Y., Twaddle, A., Fitch, A., Santos, C., Min, J.-Y., Journal of Virology, 2013, 10.1128/JVI.01016-13

Induction of protective immunity against influenza A/Jiangxi-Donghu/346/2013 (H10N8) in mice, Lau, Y.-F., Subbarao, K., Lamirande, E., Sin, W.-L., Lim, J.-H., Sutton, T., Tang, L.-H., Kuah, L.-F., Journal of General Virology, 2017, 10.1099/jgv.0.000683

The temperature-sensitive and attenuation phenotypes conferred by mutations in the influenza virus PB2, PB1, and NP genes are influenced by the species of origin of the PB2 gene in reassortant viruses derived from influenza A/California/07/2009 and A/WSN/33 viruses, Subbarao, K., Godbout, R.A., Santos, C.P., Broadbent, A.J., Journal of Virology, 2014, 10.1128/JVI.02142-14

Moving on Out: Transport and Packaging of Influenza Viral RNA into Virions, Subbarao, K., Fodor, E., Lakdawala, S.S., Annual Review of Virology, 2016, 10.1146/annurev-virology-110615-042345

Influenza vaccines: present and future., Subbarao, K., Advances in virus research, 1999

Comparison of two enzyme-linked immunosorbent assay (EIA) kits with immunofluorescence and isolation in cell culture for detection of respiratory syncytial virus (RSV), Waner, J.L., Subbarao, E.K., Whitehurst, N.J., Diagnostic Microbiology and Infectious Disease, 1987, 10.1016/0732-8893(87)90054-X

Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: Similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong, Guo, Y., Cox, N.J., Subbarao, K., Xu, X., Virology, 1999, 10.1006/viro.1999.9820

Neuraminidase stalk length and additional glycosylation of the hemagglutinin influence the virulence of influenza H5N1 viruses for mice, Subbarao, K., Donis, R., Altholtz, M., Warnes, C., Naffakh, N., Rameix-Welti, M.-A., Thomas, C., Swayne, D.E., Matsuoka, Y., Journal of Virology, 2009, 10.1128/JVI.01987-08

Pause on avian flu transmission research, Webster, R.G., Webby, R.J., Tumpey, T.M., Tripp, R.A., Thomas, P.G., Taubenberger, J.K., Tashiro, M., Takimoto, T., Swayne, D.E., Subbarao, K., Steel, J., Schultz-Cherry, S., Richt, J.A., Perez, D.R., Peiris, J.S.M., Palese, P., Osterhaus, A.D.M.E., Mettenleiter, T.C., Lowen, A., Liu, X., Liu, J., Kobinger, G., Klenk, H.D., Katz, J., Guan, Y., Feldmann, H., Donis, R.O., Doherty, P.C., Cox, N.J., Couch, R.B., Compans, R.W., Chen, H., Capua, I., Brown, I.H., Bouvier, N.M., Barclay, W.S., Kawaoka, Y., García-Sastre, A., Fouchier, R.A.M., Science, 2012, 10.1126/science.1219412

B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination., Subbarao, K., Topham, D.J., Treanor, J.J., Wright, P.F., Zand, M.S., Luke, C.J., Yang, H., Krammer, F., Henn, A.D., Sundararajan, A., Ilyushina, N.A., Fitzgerald, T., Santiago, F.W., Baer, J., Sangster, M.Y., Clinical and vaccine immunology : CVI, 2013

Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection, Wilson, P.C., Krammer, F., Palese, P., Subbarao, K., Topham, D.J., Treanor, J.J., Terajima, M., Ennis, F.A., Mullarkey, C.E., Zheng, N.-Y., Hirsh, A., Cruz, J., Tan, G.S., Ho, I.Y., Chromikova, V., Choi, A., Huang, M., Leon, P.E., Henry Dunand, C.J., Cell Host and Microbe, 2016, 10.1016/j.chom.2016.05.014

A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys, Subbarao, K., Jin, H., Kemble, G., Swayne, D., Lu, B., Matsuoka, Y., Vogel, L., Min, J.-Y., Journal of Virology, 2010, 10.1128/JVI.01305-10

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS, Collins, P.L., Subbarao, K., Murphy, B.R., St Claire, M., Elkins, W.R., Vogel, L.N., Buchholz, U.J., Lamirande, E.W., Bukreyev, A., Lancet, 2004, 10.1016/S0140-6736(04)16501-X

Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets, Matsuoka, Y., Jin, H., Subbarao, K., Santos, C., Paskel, M., Lu, J., Baz, M., Chen, Z., Journal of Virology, 2014, 10.1128/JVI.00100-14

An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults, Subbarao, K., Kemble, G.W., Coelingh, K.L., Lamirande, E.W., Jin, H., Min, J.-Y., Chen, G.L., Thumar, B., Luke, C.J., Mcmahon, B.A., Liang, P.H., Karron, R.A., Talaat, K.R., Influenza and other Respiratory Viruses, 2013, 10.1111/j.1750-2659.2012.00350.x

Long-read RNA sequencing identifies polyadenylation elongation and differential transcript usage of host transcripts during SARS-CoV-2 in vitro infection, Lachlan J.M. Coin, Timothy P. Stinear, Kanta Subbarao, Michael B. Clark, Sarah L. Londrigan, Francesca L. Mordant, Chenxi Zhou, Ricardo De Paoli-Iseppi, Miranda E. Pitt, Daniel Rawlinson, Josie Gleeson, Jessie J.-Y. Chang, 2021, 10.1101/2021.12.14.472725

Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates, Subbarao, K., Jin, H., Chen, Z., Lu, J., Matsuoka, Y., Paskel, M., Santos, C.P., Broadbent, A.J., Vaccine, 2015, 10.1016/j.vaccine.2014.10.065

Sequential addition of temperature-sensitive missense mutations into the PB2 gene of influenza a transfectant viruses can effect an increase in temperature sensitivity and attenuation and permits the rational design of a genetically engineered live influenza A virus vaccine, Murphy, B.R., Lawson, C.M., Chen, A.Y., Park, E.J., Subbarao, E.K., Journal of Virology, 1995

Immunogenicity and protective efficacy in mice and hamsters of a β-propiolactone inactivated whole virus SARS-CoV vaccine, Subbarao, K., Vassilev, V., Ward, J.M., Chen, J., Knott, I., Goossens, G., Baras, B., Vogel, L., Lamirande, E.W., Roberts, A., Viral Immunology, 2010, 10.1089/vim.2010.0028

Antigen-activated dendritic cells ameliorate influenza A infections, Subbarao, K., Talor, E., Zimmerman, D., Orandle, M., Vogel, L., Boonnak, K., Journal of Clinical Investigation, 2013, 10.1172/JCI67550

Mammalian infections with highly pathogenic avian influenza viruses renew concerns of pandemic potential, Kanta Subbarao, Brad Gilbertson, Journal of Experimental Medicine, 2023, 10.1084/jem.20230447

The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon, Fodor, E., Subbarao, K., Carr, S.M., McCall, A.W., Lau, Y.-F., Vreede, F.T., Graef, K.M., Journal of Virology, 2010, 10.1128/JVI.00879-10

β-Microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase, Murphy, B.R., Connors, M., Subbarao, E.K., Lawson, C.M., Misplon, J.A., Epstein, S.L., Journal of Immunology, 1993

Comparative study of influenza virus epithelium cells derived from adenoids and airway replication in MDCK cells and in primary, Wright, P.F., Subbarao, K., Treanor, J.J., Rudenko, L.G., Kawaoka, Y., Ikizler, M.R., Ilyushina, N.A., Journal of Virology, 2012, 10.1128/JVI.01477-12

The prospects and challenges of universal vaccines for influenza, Matsuoka, Y., Subbarao, K., Trends in Microbiology, 2013, 10.1016/j.tim.2013.04.003

Reassortment and evolution of current human influenza A and B viruses, Klimov, A., Cox, N.J., Subbarao, K., Mungall, B.A., Hall, H.E., Smith, C.B., Shaw, M.W., Lindstrom, S.E., Xu, X., Virus Research, 2004, 10.1016/j.virusres.2004.02.013

Immunohistochemical and in situ hybridization studies of influenza A virus infection in human lungs, Zaki, S.R., Cox, N., Freifeld, A., Nolte, K.B., Morken, T., Ferebee, T., Shaw, M., Subbarao, K., Shieh, W.-J., Dawson, J., Guarner, J., American Journal of Clinical Pathology, 2000, 10.1309/HV74-N24T-2K2C-3E8Q

Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of Mice, Murphy, B., Zaki, S., Shieh, W.-J., Packard, M., Tatti, K., Fischer, S., Fahle, G., Vogel, L., McAuliffe, J., Subbarao, K., Journal of Virology, 2004, 10.1128/JVI.78.7.3572-3577.2004

Cellular targets for influenza drugs, Subbarao, K., Min, J.-Y., Nature Biotechnology, 2010, 10.1038/nbt0310-239

Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19, Hans Juergen Netter, Julian Druce, Leon Caly, Kanta Subbarao, Mike Catton, Francesca Mordant, Pamela Konecny, Andrew Lloyd, Nicole Gilroy, Bernard Hudson, Jeffrey J. Post, Michael MIna, William Rawlinson, Marianne Martinello, Rowena Bull, Suellen Nicholson, Marilou H. Barrios, Microorganisms, 2023, 10.3390/microorganisms11081985

Toxicological evaluation of live attenuated, cold-adapted H5N1 vaccines in ferrets, Coelingh, K.L., Kemble, G., Murphy, B., Subbarao, K., Luke, C., Leininger, J., Manetz, S., Jin, H., Vaccine, 2007, 10.1016/j.vaccine.2007.10.032

Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques, Adam K. Wheatley, Stephen J. Kent, Kanta Subbarao, Francesca L. Mordant, Thakshila Amarasena, Robyn Esterbauer, Kathleen M. Wragg, Hannah G. Kelly, Isaac Barber-Axthelm, Wen Shi Lee, Jennifer A. Juno, Hyon-Xhi Tan, Nature Communications, 2021, 10.1038/s41467-021-21665-8

Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine, Lanzavecchia, A., Subbarao, K., Sallusto, F., Weiss, R.A., Temperton, N.J., Torres-Velez, F.J., Luke, C.J., Santos, C., Vanzetta, F., Fernandez-Rodriguez, B.M., Silacci, C., Pinna, D., Suguitan Jr., A.L., Corti, D., Journal of Clinical Investigation, 2010, 10.1172/JCI41902

Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus, Subbarao, K., Katze, M.G., Tumpey, T.M., Chen, J., Vogel, L., Teal, T.H., Roberts, A., Baas, T., Journal of Virology, 2008, 10.1128/JVI.00489-08

A new route to vaccines using PROTACs, Kanta Subbarao, Brad Gilbertson, Nature Biotechnology, 2022, 10.1038/s41587-022-01406-y

Molecular changes associated with the transmission of avian influenza A H5N1 and H9N2 viruses to humans, Subbarao, K., Shortridge, K., Lim, W., Webster, R., Cox, N., Klimov, A., Zhou, N., Guan, Y., Krauss, S., Thompson, W., Xu, X., Cooper, L., Shaw, M., Journal of Medical Virology, 2002, 10.1002/jmv.2118

Predicting the efficacy of variant-modified COVID-19 vaccine boosters, Deborah Cromer, Miles P. Davenport, Stephen J. Kent, Kanta Subbarao, Steffen S. Docken, David S. Khoury, Nature Medicine, 2023, 10.1038/s41591-023-02228-4

Lymphopenia associated with highly virulent H5N1 virus infection due to plasmacytoid dendritic cell-mediated apoptosis of T cells, Subbarao, K., Legge, K.L., Feldmann, H., Feldmann, F., Vogel, L., Boonnak, K., Journal of Immunology, 2014, 10.4049/jimmunol.1302992

Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets, Subbarao, K., Kemble, G., Jin, H., Lamirande, E.W., Chen, G.L., Virology, 2010, 10.1016/j.virol.2009.12.003

SARS vaccine protective in mice [2], Subbarao, K., Abrignani, S., Rappuoli, R., Murphy, B., Klenk, H.-D., Kolesnikova, L., Eickmann, M., Vogel, L., Becker, S., Roberts, A., Stadler, K., Emerging Infectious Diseases, 2005

Evaluation of replication and pathogenicity of avian influenza A H7 subtype viruses in a mouse model, Subbarao, K., Kemble, G., Jin, H., Lu, B., McAuliffe, J., Joseph, T., Journal of Virology, 2007, 10.1128/JVI.00970-07

H5N1 viruses and vaccines, Subbarao, K., Luke, C., PLoS Pathogens, 2007, 10.1371/journal.ppat.0030040

Molecular aspects of avian influenza (H5N1) viruses isolated from humans, Shaw, M.W., Subbarao, K., Reviews in Medical Virology, 2000, 10.1002/1099-1654(200009/10)10:5<337::AID-RMV292>3.0.CO;2-V

Rapid detection of respiratory syncytial virus by a biotin–enhanced immunoassay: Test performance by laboratory technologists and housestaff, Kumar, M.L., Thomas, F., Super, D.M., Black, C.J., De Sierra, T.M., Dietrich, M.C., Subbarao, E.K., Pediatric Infectious Disease Journal, 1989

The attenuation phenotype conferred by the M gene of the influenza A/Ann Arbor/6/60 cold-adapted virus (H2N2) on the A/Korea/82 (H3N2) reassortant virus results from a gene constellation effect, Murphy, B.R., Treanor, J.J., Perkins, M., Subbarao, E.K., Virus Research, 1992, 10.1016/0168-1702(92)90098-T

Implications of the apparent extinction of B/Yamagata-lineage human influenza viruses, Kanta Subbarao, Ian G. Barr, npj Vaccines, 2024, 10.1038/s41541-024-01010-y

Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine, Roberts, A., Subbarao, K., Vogel, L., Lamirande, E., Rose, J.K., Kapadia, S.U., Virology, 2005, 10.1016/j.virol.2005.06.016

Prevaccination serologic screening for measles in health care workers, Kumar, M.L., Amin, S., Subbarao, E.K., Journal of Infectious Diseases, 1991

Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins, Denison, M.R., Subbarao, K., Lu, X., McAuliffe, J., Prentice, E., Journal of Virology, 2004, 10.1128/JVI.78.18.9977-9986.2004

The role of animal models in influenza vaccine research, Subbarao, K., Luke, C.J., Birkhauser Advances in Infectious Diseases, 2011, 10.1007/978-3-0346-0279-2_10

Receptor specificity does not affect replication or virulence of the 2009 pandemic H1N1 influenza virus in mice and ferrets, Subbarao, K., Sasisekharan, R., Paskel, M., Moore, I., Lamirande, E.W., Jayaraman, A., Shih, A.R., Lakdawala, S.S., Virology, 2013, 10.1016/j.virol.2013.08.011

Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus, Subbarao, K., Jin, H., Lindsley, W.G., Matsuoka, Y., Vogel, L., Santos, C.P., Wang, W., Suguitan, A.L., Lamirande, E.W., Lakdawala, S.S., PLoS Pathogens, 2011, 10.1371/journal.ppat.1002443

An influenza A live attenuated reassortant virus possessing three temperature-sensitive mutations in the PB2 polymerase gene rapidly loses temperature sensitivity following replication in hamsters, Gottlieb, P., Subbarao, K., Park, E.J., Murphy, B.R., Vaccine, 1997, 10.1016/S0264-410X(97)00031-5

Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus, Subbarao, K., Sutton, T.C., Virology, 2015, 10.1016/j.virol.2015.02.030

Development of effective vaccines against pandemic influenza, Fauci, A.S., Murphy, B.R., Subbarao, K., Immunity, 2006, 10.1016/j.immuni.2005.12.005

A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice., Subbarao, K., Baric, R., Zaki, S.R., Genrich, G.L., Heise, M., Sheahan, T., Herman, B.D., Vogel, L., Yount, B., Cheng, A., Paddock, C.D., Deming, D., Roberts, A., PLoS pathogens, 2007, 10.1371/journal.ppat.0030005

Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults, Subbarao, K., Kemble, G., Murphy, B.R., Jin, H., Coelingh, K., Lamirande, E., Chen, G., Mills, K., Suguitan, A., Schappell, E., McAuliffe, J., DiLorenzo, S., Thumar, B., Callahan, K., Luke, C., Talaat, K., Karron, R.A., Vaccine, 2009, 10.1016/j.vaccine.2009.05.099

Heterovariant cross-reactive B-cell responses induced by the 2009 pandemic influenza virus A subtype H1N1 vaccine, Greenberg, H.B., Subbarao, K., Dekker, C.L., Jin, H., Sangster, M.Y., Topham, D.J., Treanor, J.J., Golding, H., Khurana, S., Baer, J., Sasaki, S., He, X.-S., Journal of Infectious Diseases, 2013, 10.1093/infdis/jis664

The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell death, Lenardo, M.J., Subbarao, K., Baric, R.S., Xu, X.-N., Zaki, S.R., Lippincott-Schwartz, J., Screaton, G.R., Buchholz, U.J., Frieman, M.B., Liu, W., Yount, B., Cheng, A., Welsh, S., Goldsmith, C.S., Yu, L., Freundt, E.C., Journal of Virology, 2010, 10.1128/JVI.01662-09

An efficient method to make human monoclonal antibodies from memory B cells: Potent neutralization of SARS coronavirus, Lanzavecchia, A., Rappuoli, R., Murphy, B.R., Gismondo, M.R., Uematsu, Y., Kolesnikova, L., Subbarao, K., Becker, S., Traggiai, E., Nature Medicine, 2004, 10.1038/nm1080

What level of neutralising antibody protects from COVID-19?, Miles P Davenport, James A Triccas, Stephen J Kent, Kanta Subbarao, Jennifer A Juno, Adam K Wheatley, Timothy E Schlub, Arnold Reynaldi, Deborah Cromer, David S Khoury, 2021, 10.1101/2021.03.09.21252641

SARS CoV subunit vaccine: Antibodymediated neutralisation and enhancement, Altmeyer, R., Nal, B., Peiris, J.S.M., Subbarao, K., Bruzzone, R., Daeron, M., Escriou, N., Dutry, I., Li, P.H., Roberts, A., Kien, F., Cheung, C.Y., Kam, Y.W., Yip, M.S., Jaume, M., Hong Kong Medical Journal, 2012

A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo, Enjuanes, L., Subbarao, K., Zaki, S.R., Shieh, W.-J., Roberts, A., Lamirande, E., Rejas, M.T., Almazán, F., Álvarez, E., DeDiego, M.L., Journal of Virology, 2007, 10.1128/JVI.01467-06

Live attenuated influenza vaccine, Subbarao, K., Jin, H., Current Topics in Microbiology and Immunology, 2015

A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets, Subbarao, K., Kemble, G., Jin, H., Swayne, D., Vogel, L., Lu, B., McAuliffe, J., Joseph, T., Virology, 2008, 10.1016/j.virol.2008.05.021

Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998, Subbarao, K., Lim, W., Cameron, K., Gregory, V., Hay, A., Cox, N., Klimov, A., Bender, C., Huang, J., Hall, H., Virology, 1999, 10.1006/viro.1998.9529

The 2009 pandemic H1N1 virus induces anti-neuraminidase (NA) antibodies that cross-react with the NA of H5N1 viruses in ferrets, Jin, H., Subbarao, K., Kim, L., Chen, Z., Vaccine, 2012, 10.1016/j.vaccine.2012.01.090

Refining the approach to vaccines against influenza A viruses with pandemic potential, Subbarao, K., Czako, R., Future Virology, 2015, 10.2217/fvl.15.69

Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII-dependent entry into B cells in vitro, Altmeyer, R., Nal, B., Peiris, M., Subbarao, K., Zaki, S.R., Guarner, J., Tse, J., Chu, S.L., Vogel, L., Lamirande, E.W., Cheung, Y.C., Roberts, A., Kien, F., Kam, Y.W., Vaccine, 2007, 10.1016/j.vaccine.2006.08.011

Transcript of the question and answer sessions from the Fifth International Symposium on Avian Influenza, Marsh-Johnson, T., Preston, K., Hatkins, J., Byrd, C., Akey, B., Collins, R., Dybkaer, K., Perdue, M., Pasick, J., Spackman, E., Gonder, E., Fernandez, R., Tollis, M., Silim, A., Ehlers, M., Holt, P., Naeem, K., Erasmus, B., Cox, N., Anthony, C., Tam, G., Pittman, M., Kounev, Z., Pearson, J., Myers, T.J., Pharo, H., Rudd, K., Bright, R., Beard, C., Shirley, L., Schultz-Cherry, S., Marangon, S., Banks, J., Lu, H., Tumpey, T., Rowe, T., Matsuoka, Y., Katz, J., Swayne, D., Stohr, K., Bridge, C., Reid, A., Bublot, M., Perez, D.R., Webby, R., Koch, G., Lindstrom, S., Peiris, M., McCullers, J., Won Lee, C., Koch, G., Subbarao, K., Trock, S., Senne, D., Kawaoka, Y., O'Conner, R., Burns, K., Cattoli, G., Romero, C., Campitelli, L., Geale, D., Hanson, B., Webster, R., Karunakaran, D., Jestin, V., Kuhne, P.J.G., Henzler, D., Van Der Goot, J., Fouchier, R., Cardona, C., Brown, I., Halvorson, D., Miles, A., Suarez, D., Mutinelli, F., Trock, S., Michel, B., Capua, I., Sims, L., Glauer, D., Cutler, G., Slemons, R., Zanella, A., Donahoe, J., Alexander, D., Rivera, E., Naeem, K., Dunn, P., Eckroade, R., Kinde, H., Selleck, P., Perez, D., Woolcock, P., Swayne, D.E., Avian Diseases, 2003

H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines, Jin, H., Kemble, G., Subbarao, K., Kulkarni, D., Zhou, H., Xu, Q., Eisenbraun, M., Cheng, X., PLoS ONE, 2009, 10.1371/journal.pone.0004436

Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets, Subbarao, K., Kemble, G., Swayne, D.E., Murphy, B., Luke, C.J., Lu, B., Duke, G., Jin, H., Mills, K.L., McAuliffe, J., Suguitan Jr., A.L., PLoS Medicine, 2006, 10.1371/journal.pmed.0030360

Boosted influenza-specific T cell responses after H5N1 pandemic live attenuated influenza virus vaccination, Dong, T., Subbarao, K., McMichael, A., Luke, C.J., Dong, D., Zeng, H., Powell, T.J., Karron, R., Wang, B., Talaat, K., Peng, Y., Frontiers in Immunology, 2015, 10.3389/fimmu.2015.00287

Molecular epidemiology of influenza A(H3N2) virus reinfections, Glezen, W.P., Taber, L.H., Subbarao, K., Cox, N.J., Smith, C.B., Journal of Infectious Diseases, 2002, 10.1086/339416

Effective immunization with live attenuated influenza A virus can be achieved in early infancy, Wright, P.F., Wilson, M.H., Subbarao, K., Steinhoff, M.C., Murphy, B.R., Karron, R.A., Makhene, M.K., Clements, M.L., Journal of Infectious Diseases, 1996

Live attenuated and inactivated influenza vaccines in children, Wright, P.F., Subbarao, K., Luke, C.J., Treanor, J.J., Ackerman, M.E., Brown, E.P., Housman, M.L., Khalenkov, A.M., Hoen, A.G., Haynes, B.C., Ilyushina, N.A., Journal of Infectious Diseases, 2015, 10.1093/infdis/jiu458

Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate, Subbarao, K., Murphy, B.R., Cox, N.J., Chen, Q., Swayne, D., Matsuoka, Y., Chen, H., Vaccine, 2003, 10.1016/S0264-410X(03)00430-4

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice, Moss, B., Subbarao, K., Murphy, B.R., Collins, P.L., Bukreyev, A., Vogel, L., Roberts, A., Bisht, H., Proceedings of the National Academy of Sciences of the United States of America, 2004, 10.1073/pnas.0401939101

Global epidemiology of influenza: Past and present, Subbarao, K., Cox, N. J., Annual Review of Medicine, 2000, 10.1146/annurev.med.51.1.407

The contribution of systemic and pulmonary immune effectors to vaccine-induced protection from H5N1 influenza virus infection, Subbarao, K., Wright, A.R., Lau, Y.-F., Journal of Virology, 2012, 10.1128/JVI.07205-11

The multibasic cleavage site of the hemagglutinin of highly pathogenic a/vietnam/1203/2004 (H5N1) avian influenza virus acts as a virulence factor in a host-specific manner in mammals, Subbarao, K., Orandle, M., Cheng, L.I., Vogel, L., Santos, C.P., Matsuoka, Y., Lau, Y.-F., Suguitan Jr., O.L., Journal of Virology, 2012, 10.1128/JVI.05546-11

Prophylaxis with a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits from MERS-CoV Infection, Subbarao, K., Dimitrov, D.S., Moore, I.N., Bock, K.W., Lamirande, E.W., Vogel, L., Wang, Y., Ying, T., Gretebeck, L., Houser, K.V., Journal of Infectious Diseases, 2016, 10.1093/infdis/jiw080

Effect of priming with H1N1 influenza viruses of variable antigenic distances on challenge with 2009 pandemic H1N1 virus, Subbarao, K., Nabel, G.J., Wei, C.-J., Wright, A., Vogel, L.N., O'Donnell, C.D., Journal of Virology, 2012, 10.1128/JVI.00147-12

Vaccines for pandemic influenza, Subbarao, K., Luke, C.J., Emerging Infectious Diseases, 2006

H5N1 vaccines in humans, Subbarao, K., Jin, H., Cheng, X., Luke, C.J., Baz, M., Virus Research, 2013, 10.1016/j.virusres.2013.05.006

Can immunity induced by the human influenza virus N1 neuraminidase provide some protection from avian influenza H5N1 viruses?, Subbarao, K., Gillim-Ross, L., PLoS Medicine, 2007, 10.1371/journal.pmed.0040091

The Critical Interspecies Transmission Barrier at the Animal–Human Interface, Kanta Subbarao, Tropical Medicine and Infectious Disease, 2019, 10.3390/tropicalmed4020072

DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice, Katz, J.M., Sambhara, S., Renshaw, M., Subbarao, K., Cooper, L.A., Lo, C.-Y., Misplon, J.A., Tumpey, T.M., Epstein, S.L., Emerging Infectious Diseases, 2002

Influenza vaccines generated by reverse genetics, Katz, J.M., Subbarao, K., Current Topics in Microbiology and Immunology, 2004

A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in Golden Syrian hamsters, Subbarao, K., Enjuanes, L., Baric, R., Zaki, S.R., Shieh, W.-J., Sheahan, T., Alvarez, E., Jackson, J.P., Roberts, A., DeDiego, M.L., Lamirande, E.W., Journal of Virology, 2008, 10.1128/JVI.00304-08

Memory CD4 ⁺ T cells: Beyond "helper" functions, Subbarao, K., Boonnak, K., Journal of Clinical Investigation, 2012, 10.1172/JCI65208

Are there alternative avian influenza viruses for generation of stable attenuated avian-human influenza A reassortant viruses?, Murphy, B.R., Kawaoka, Y., Webster, R.G., Subbarao, K., Virus Research, 1995, 10.1016/0168-1702(95)00082-8

A second external quality assessment of isolation and identification of influenza viruses in cell culture in the Asia Pacific region highlights improved performance by participating laboratories, Patrick C. Reading, Magdi Samaan, Francis Y. Inbanathan, Karen Nahapetyan, Ian G. Barr, Kanta Subbarao, Tasoula Zakis, Iwona Buettner, Heidi Peck, Angela Todd, Yi-Mo Deng, Vivian K.Y. Leung, Journal of Clinical Virology, 2021, 10.1016/j.jcv.2021.104907

The soft palate is an important site of adaptation for transmissible influenza viruses, Subbarao, K., Sasisekharan, R., Wentworth, D.E., Das, S.R., Orandle, M., Moore, I., Minai, M., Paskel, M., Vogel, L., Hanson, C.T., Simenauer, A., Lin, X., Stockwell, T.B., Shih, A.R., Lamirande, E.W., Halpin, R.A., Jayaraman, A., Lakdawala, S.S., Nature, 2015, 10.1038/nature15379

The ongoing battle against influenza: The challenge of flu transmission., Subbarao, K., Lakdawala, S.S., Nature medicine, 2012

Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine, Kanta Subbarao, Kylie M. Quinn, Annette Fox, Drugs, 2018, 10.1007/s40265-018-0958-7

Avian influenza virus glycoproteins restrict virus replication and spread through human airway epithelium at temperatures of the proximal airways, Pickles, R.J., Barclay, W.S., Subbarao, K., Bordonali, E., Roberts, K.L., Santos, C., Gillim-Ross, L., Scull, M.A., PLoS Pathogens, 2009, 10.1371/journal.ppat.1000424

A single amino acid in the PB2 gene of influenza A virus is a determinant of host range, Murphy, B.R., London, W., Subbarao, E.K., Journal of Virology, 1993

Heparin Inhibits SARS-CoV-2 Replication in Human Nasal Epithelial Cells, Jessica, Kanta Subbarao, Paul Monagle, Gary P. Anderson, Michael W. Parker, Craig Morton, Phil Robinson, Damian Purcell, Vera Ignjatovic, Conor McCafferty, Randy Suryadinata, Leo Yi Yang Lee, Viruses, 2022, 10.3390/v14122620

Passive immunization with influenza haemagglutinin specific monoclonal antibodies, Kanta Subbarao, Rajeev Rudraraju, Human Vaccines & Immunotherapeutics, 2018, 10.1080/21645515.2018.1489947

Evaluation of replication and cross-reactive antibody responses of H2 subtype influenza viruses in mice and ferrets, Subbarao, K., Kemble, G., Jin, H., Yang, C.-F., Lamirande, E.W., Chen, G.L., Journal of Virology, 2010, 10.1128/JVI.00511-10

Classical swine H1N1 influenza viruses confer cross protection from swine-origin 2009 pandemic H1N1 influenza virus infection in mice and ferrets, Subbarao, K., Matsuoka, Y., Lamirande, E.W., Santos, C., Chen, G.L., Min, J.-Y., Virology, 2010, 10.1016/j.virol.2010.09.009

Safety and immunogenicity of a cold–adapted influenza a (H1N1) reassortant virus vaccine administered to infants less than six months of age, Murphy, B.R., Fries, L.F., Clements, M.L., MaCleod, K., Wilson, M.H., Subbarao, E.K., Steinhoff, M.C., Karron, R.A., Pediatric Infectious Disease Journal, 1995

Live Attenuated Influenza Vaccines for Pandemic Preparedness, Kanta Subbarao, Journal of the Pediatric Infectious Diseases Society, 2020, 10.1093/jpids/piz073

Genetic characterization of H3N2 influenza viruses isolated from pigs in North America, 1977-1999: Evidence for wholly human and reassortant virus genotypes, Olsen, C.W., Carman, S., Anderson, G.A., Subbarao, K., Smith, C.B., Cooper, L.A., Schutten, M.M., Karasin, A.I., Virus Research, 2000, 10.1016/S0168-1702(00)00154-4

The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines, Subbarao, K., Jin, H., Matsuoka, Y., Vogel, L., O'Donnell, C.D., Journal of Virology, 2014, 10.1128/JVI.01107-14

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice, Nabel, G.J., Subbarao, K., Murphy, B.R., Roberts, A., Huang, Y., Kong, W.-P., Yang, Z.-Y., Nature, 2004, 10.1038/nature02463

Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine, Katz, J.M., Robinson, H.L., Subbarao, K., Ross, T.M., Bright, R.A., Virology, 2003, 10.1016/S0042-6822(03)00008-4

Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia, Kirsten M. Spann, James S. McCarthy, Lia van der Hoek, Eileen V. Roulis, Bridget E. Barber, Siddhartha Mahanty, Kanta Subbarao, Sean A. Lynch, Viruses, 2021, 10.3390/v13081618

Detection of multiple viral agents in nasopharyngeal specimens yielding Respiratory Syncytial Virus (RSV). An assessment of diagnostic strategy and clinical significance, Waner, J.L., Griffis, J., Subbarao, E.K., Diagnostic Microbiology and Infectious Disease, 1989, 10.1016/0732-8893(89)90098-9

Evaluation of replication, immunogenicity and protective efficacy of a live attenuated cold-adapted pandemic H1N1 influenza virus vaccine in non-human primates, Subbarao, K., Vogel, L., Matsuoka, Y., Paskel, M., Boonnak, K., Vaccine, 2012, 10.1016/j.vaccine.2012.06.088

Correlates of protection, thresholds of protection, and immunobridging in SARS-CoV-2 infection, Miles P Davenport, Stephen J Kent, James A Triccas, Kanta Subbarao, Peter B Gilbert, Youyi Fong, Megan Steain, Deborah Cromer, Timothy E Schlub, David S Khoury, 2022, 10.1101/2022.06.05.22275943

Polygenic virulence factors involved in pathogenesis of 1997 Hong Kong H5N1 influenza viruses in mice, Matsuoka, Y., Katz, J.M., Cox, N.J., Smith, C., Subbarao, K., Bright, R.A., Chen, H., Virus Research, 2007, 10.1016/j.virusres.2007.04.017

Animal models for SARS., Subbarao, K., Roberts, A., Advances in experimental medicine and biology, 2006

Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models, Miles P. Davenport, Stephen J. Kent, David H. O’Connor, Kanta Subbarao, Deborah Cromer, Arnold Reynaldi, Mitchell D. Ramuta, Adam K. Wheatley, David S. Khoury, Nature Reviews Immunology, 2020, 10.1038/s41577-020-00471-1

Replication and immunogenicity of swine, equine, and avian H3 subtype influenza viruses in mice and ferrets, Subbaraoa, K., Jin, H., Cheng, X., Zengel, J., Matsuoka, Y., Paskel, M., Baz, M., Journal of Virology, 2013, 10.1128/JVI.03520-12

Evaluation of three live attenuated H2 pandemic influenza vaccine candidates in mice and ferrets, Subbarao, K., Kemble, G., Jin, H., Orandle, M., Torres-Velez, F., Cheng, X., Lamirande, E.W., Chen, G.L., Journal of Virology, 2014, 10.1128/JVI.01829-13

B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination, Subbarao, K., Topham, D.J., Treanor, J.J., Wright, P.F., Zand, M.S., Luke, C.J., Yang, H., Krammer, F., Henn, A.D., Sundararajan, A., Ilyushina, N.A., Fitzgerald, T., Santiago, F.W., Baer, J., Sangster, M.Y., Clinical and Vaccine Immunology, 2013, 10.1128/CVI.00735-12

Animal models and antibody assays for evaluating candidate SARS vaccines: Summary of a technical meeting 25-26 August 2005, London, UK, Cherian, T., Wood, D., Ferguson, M., Subbarao, K., Wood, J., Roberts, A., Vaccine, 2006, 10.1016/j.vaccine.2006.07.009

Convalescent plasma treatment for COVID‐19: Tempering expectations with the influenza experience, Rajeev Rudraraju, Francesca Mordant, Kanta Subbarao, European Journal of Immunology, 2020, 10.1002/eji.202048723

Contributions of the structural proteins of severe respiratory syndrome coronavirus to protective immunity, Collins, P.L., Subbarao, K., Murphy, B.R., Lamirande, E.W., Yang, L., Bukreyev, A., Buchholz, U.J., Proceedings of the National Academy of Sciences of the United States of America, 2004, 10.1073/pnas.0403492101

Nonreplicating influenza a virus vaccines confer broad protection against lethal challenge, Subbarao, K., Townsend, A., Powell, T., Santos, C., Paskel, M., Boonnak, K., Baz, M., mBio, 2015, 10.1128/mBio.01487-15

Emerging respiratory viruses: Challenges and vaccine strategies, Subbarao, K., Gillim-Ross, L., Clinical Microbiology Reviews, 2006, 10.1128/CMR.00005-06

Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease, Baric, R.S., Subbarao, K., Scorpio, D., Woodruff, B., Vogel, L., Roberts, A., Donaldson, E., Page, C., Agnihothram, S., Yount, B., Frieman, M., Journal of Virology, 2012, 10.1128/JVI.05957-11

The challenge of flu transmission, Subbarao, K., Lakdawala, S.S., Nature Medicine, 2012, 10.1038/nm.2953

The Pandemic Threat of Avian Influenza Viruses, Subbarao, K., Suguitan Jr., A.L., Perspectives in Medical Virology, 2006, 10.1016/S0168-7069(06)16005-X

Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge, Subbarao, K., Rosenberger, C.M., Treanor, J., Wright, P.F., Yewdell, J.W., McBride, J.M., Wieland-Alter, W.F., Sangster, M.Y., Luke, C., Hickman, H.D., Jegaskanda, S., Journal of Infectious Diseases, 2016, 10.1093/infdis/jiw262

An adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza virus vaccine with antigen-sparing effect in mice, Subbarao, K., Ooi, E.-E., McCall, A.W., Tang, L.-H., Lau, Y.-F., Journal of Virology, 2010, 10.1128/JVI.00596-10

Is there an ideal animal model for SARS?, Roberts, A., Subbarao, K., Trends in Microbiology, 2006, 10.1016/j.tim.2006.05.007

Severity of clinical disease and pathology in ferrets experimentally infected with influenza viruses is influenced by inoculum volume, Subbarao, K., Qin, J., Donahue, D., Paskel, M., Lamirande, E.W., Moore, I.N., Journal of Virology, 2014, 10.1128/JVI.02341-14

Evaluation of live attenuated influenza A virus H6 vaccines in mice and ferrets, Subbarao, K., Kemble, G., Jin, H., Gillim-Ross, L., Aspelund, A., Santos, C., Chen, Z., Journal of Virology, 2009, 10.1128/JVI.01775-08

Serologic screening, mass immunization, and implications for immunization programs [2], Kumar, M.L., Amin, S., Subbarao, E.K., Markowitz, L., Grabowsky, M., Journal of Infectious Diseases, 1991

Respiratory Virus Vaccines, Subbarao, K., Boonnak, K., Broadbent, A.J., Mucosal Immunology: Fourth Edition, 2015, 10.1016/B978-0-12-415847-4.00059-8

Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans, Subbarao, K., Zaki, S., Butler, E., Vogel, L., Paddock, C., Roberts, A., Journal of Virology, 2005, 10.1128/JVI.79.9.5833-5838.2005

Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza, Subbarao, K., Lanzavecchia, A., De Jong, M.D., Do, Q.H., Farrar, J., Sallusto, F., Tran, T.H., Chau, N.V.V., Ward, J.M., Mills, K., Suguitan Jr., A.L., Bernasconi, N.L., Simmons, C.P., PLoS Medicine, 2007, 10.1371/journal.pmed.0040178

Off‐target effects of bacillus Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2: implications for protection against severe COVID‐19, Nigel Curtis, Kanta Subbarao, Suellen Nicholson, Melanie R Neeland, Laure F Pittet, Rhian Bonnici, Rajeev Rudraraju, Rebecca McElroy, Susie Germano, Nicole L Messina, Clinical & Translational Immunology, 2022, 10.1002/cti2.1387

Mechanisms of Heterosubtypic Immunity to Lethal Influenza A Virus Infection in Fully Immunocompetent, T Cell-Depleted, β2-Microglobulin-Deficient, and J Chain-Deficient Mice, Subbarao, K., Max, E.E., Hendrickson, B.A., Lawson, C.M., Misplon, J.A., Lo, C.-Y., Epstein, S.L., Journal of Immunology, 1997

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness, Cox, N., Fukuda, K., Xu, X., Shaw, M., Rowe, T., Hemphill, M., Huang, J., Bender, C., Swayne, D., Perdue, M., Hall, H., Lim, W., Regnery, H., Katz, J., Klimov, A., Subbarao, K., Science, 1998, 10.1126/science.279.5349.393

African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates, Subbarao, K., Kemble, G., Jin, H., Marino, M., Feldmann, H., Feldmann, F., Gardner, D.J., Boonnak, K., Paskel, M., Orandle, M., Suguitan Jr., A., Matsuoka, Y., Journal of Virology, 2014, 10.1128/JVI.00425-14

Animal models for SARS and MERS coronaviruses, Subbarao, K., Gretebeck, L.M., Current Opinion in Virology, 2015, 10.1016/j.coviro.2015.06.009

Intercontinental circulation of human influenza A(H1N2) reassortant viruses during the 2001-2002 influenza season, Klimov, A., Cox, N.J., Subbarao, K., Hall, H.E., Lindstrom, S.E., Mungall, B.A., Smith, C.B., Xu, X., Journal of Infectious Diseases, 2002, 10.1086/344738

Influenza, Subbarao, K., Cox, N.J., Lancet, 1999, 10.1016/S0140-6736(99)01241-6

Animal models and vaccines for SARS-CoV infection, Subbarao, K., Baric, R., Sheahan, T., Zaki, S.R., Guarner, J., Paddock, C.D., Jackson, J.P., Vogel, L., Lamirande, E.W., Roberts, A., Virus Research, 2008, 10.1016/j.virusres.2007.03.025

Molecular correlates of influenza A H5N1 virus pathogenesis in mice, Subbarao, K., Shaw, M.W., Smith, C.B., Tumpey, T.M., Lu, X., Katz, J.M., Journal of Virology, 2000, 10.1128/JVI.74.22.10807-10810.2000

The magnitude of local immunity in the lungs of mice induced by live attenuated influenza vaccines is determined by local viral replication and induction of cytokines, Subbarao, K., Torres-Vélez, F.J., Santos, C., Lau, Y.-F., Journal of Virology, 2011, 10.1128/JVI.01564-10

Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virus, Subbarao, K., Treanor, J.J., Boonnak, K., Vogel, L., Wright, A., O'Donnell, C.D., Clinical and Vaccine Immunology, 2014, 10.1128/CVI.00790-13

Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine, Subbarao, K., Treanor, J., Katz, J., Topham, D., Jin, H., Sangster, M.Y., Luke, C., Fitzgerald, T., Levine, M., Babu, T.M., Vaccine, 2014, 10.1016/j.vaccine.2014.09.070

FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007, Wood, D., Friede, M., Luke, C.J., Subbarao, K., Weir, J., Hess, M., Golding, H., Eichelberger, M., Vaccine, 2008, 10.1016/j.vaccine.2008.06.012

A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response, Subbarao, K., Neuzil, K.M., Golding, H., Follmann, D.A., Qin, J., Lewis, K.D.C., Karron, R.A., McMahon, B.A., King, L.R., Manischewitz, J., Khurana, S., Luke, C.J., Talaat, K.R., Journal of Infectious Diseases, 2014, 10.1093/infdis/jiu123

Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein, Moss, B., Subbarao, K., Vogel, L., Roberts, A., Bisht, H., Virology, 2005, 10.1016/j.virol.2005.01.042

Safety evaluation in chickens of candidate human vaccines against potential pandemic strains of influenza, Swayne, D., Beck, J., Subbarao, K., Cox, N., Chen, H., Matsuoka, Y., Avian Diseases, 2003

Respiratory syncytial virus-specific immunoglobulins in preterm infants, Subbarao, E.K., Murphy, B.R., Wasser, T.E., Kumar, M.L., de Sierra, T.M., The Journal of Pediatrics, 1993, 10.1016/S0022-3476(06)80027-2

Potent vesicular stomatitis virus-based avian influenza vaccines provide long-term sterilizing immunity against heterologous challenge, Rose, J.K., Subbarao, K., Feldmann, H., Kobinger, G., Kobasa, D., Silaghi, A., Suguitan Jr., A.L., Buonocore, L., Schwartz, J.A., Journal of Virology, 2010, 10.1128/JVI.02637-09

Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9), Subbarao, K., Treanor, J., Luke, C., Chen, Z., Mallory, R., Fitzgerald, T., Jegaskanda, S., Matsuoka, Y., Sobhanie, M., Journal of Infectious Diseases, 2016, 10.1093/infdis/jiv526

Attacking the flu: Neutralizing antibodies may lead to 'universal' vaccine, Subbarao, K., Chen, G.L., Nature Medicine, 2009, 10.1038/nm1109-1251

Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies, Subramaniam, S., Subbarao, K., Sapiro, G., Yewdell, J.W., Das, S.R., Bliss, D., Moran, A., Kuybeda, O., Matsuoka, Y., Meyerson, J.R., Harris, A.K., Proceedings of the National Academy of Sciences of the United States of America, 2013, 10.1073/pnas.1214913110

High-affinity H7 head and stalk domain-specific antibody responses to an inactivated influenza H7N7 vaccine after priming with live attenuated influenza vaccine, Sangster, M.Y., Topham, D.J., Golding, H., Subbarao, K., Treanor, J.J., Martínez-Sobrido, L., Yang, H., Baker, S.F., Chung, K.Y., Coyle, E.M., Fitzgerald, T., Krammer, F., Khurana, S., Halliley, J.L., Journal of Infectious Diseases, 2015, 10.1093/infdis/jiv210

Evaluation of a genetically modified reassortant H5N1 influenza a virus vaccine candidate generated by plasmid-based reverse genetics, Matsuoka, Y., Cox, N., Katz, J., Lu, X., Xu, X., Brownlee, G., Fodor, E., Mingay, L., Swayne, D., Chen, H., Subbarao, K., Virology, 2003, 10.1006/viro.2002.1742

Animal models for sars, Subbarao, K., Roberts, A., Advances in Experimental Medicine and Biology, 2006, 10.1007/978-0-387-33012-9_83

Immune Responses to Avian Influenza Viruses, Kanta Subbarao, Katherine Kedzierska, Marios Koutsakos, The Journal of Immunology, 2019, 10.4049/jimmunol.1801070

Soft-Tissue Infections Caused by Mycobacterium fortuitum Complex Following Penetrating Injury, Marks, M.I., Tarpay, M.M., Subbarao, E.K., American Journal of Diseases of Children, 1987, 10.1001/archpedi.1987.04460090095037

Opposing Effects of Prior Infection versus Prior Vaccination on Vaccine Immunogenicity against Influenza A(H3N2) Viruses, Sheena G. Sullivan, H. Rogier van Doorn, Le Thi Quynh Mai, Kanta Subbarao, Ian Barr, Pham Quang Thai, Yeu-Yang Tseng, Maria Auladell, Arseniy Khvorov, Hoang Vu Mai Phuong, Vivian Leung, Louise Carolan, Annette Fox, Viruses, 2022, 10.3390/v14030470

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses, McDermott, A.B., Mascola, J.R., Kwong, P.D., Shapiro, L., Roederer, M., Ledgerwood, J.E., Koup, R.A., Graham, B.S., Douek, D.C., Subbarao, K., Mullikin, J.C., Baxa, U., Tsybovsky, Y., Matsuoka, Y., Santos, C., Yassine, H.M., Wu, X., Whittle, J.R., Wang, L., Shen, C.-H., Ransier, A., Lees, C.R., Darko, S., Bylund, T., Boyington, J.C., Asokan, M., Zhang, Y., Zhang, B., Yang, E.S., Prabhakaran, M.S., Narpala, S.N., Leung, K., Kong, W.-P., Kanekiyo, M., Gillespie, R.A., Georgiev, I.S., Druz, A., Bailer, R.T., Soto, C., Chuang, G.-Y., Thomas, P.V., Wheatley, A.K., Joyce, M.G., Cell, 2016, 10.1016/j.cell.2016.06.043

Robust and balanced immune responses to all 4 dengue virus serotypes following administration of a single dose of a live attenuated tetravalent dengue vaccine to healthy, flavivirus-naive adults, Whitehead, S.S., Subbarao, K., Fraser, E.A., Walsh, M.C., Luke, C.J., Lovchik, J.M., Jo, M., Larsson, C.J., Lyon, C.E., Sabundayo, B.P., Jarvis, A.P., Elwood, D., Diehl, S.A., Hynes, N., Grier, P.L., Tibery, C.M., Carmolli, M.P., Pierce, K.K., Durbin, A.P., Kirkpatrick, B.D., Journal of Infectious Diseases, 2015, 10.1093/infdis/jiv082

What influenza activity can we anticipate in 2022?, Kanta Subbarao, Medical Journal of Australia, 2022, 10.5694/mja2.51437

Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate, Matsuoka, Y., Cox, N., Katz, J., Lu, X., Chen, Q., Swayne, D., Subbarao, K., Chen, H., Vaccine, 2003, 10.1016/S0264-410X(02)00809-5

Transmission studies resume for avian flu, Webster, R.G., Webby, R.J., Tumpey, T.M., Tripp, R.A., Thomas, P.G., Taubenberger, J.K., Tashiro, M., Takimoto, T., Swayne, D.E., Subbarao, K., Steel, J., Schultz-Cherry, S., Richt, J.A., Perez, D.R., Peiris, J.S.M., Palese, P., Osterhaus, A.D.M.E., Mettenleiter, T.C., Lowen, A., Liu, X., Liu, J., Kobinger, G., Klenk, H.D., Kiselev, O.I., Katz, J.M., Guan, Y., Feldmann, H., Donis, R.O., Doherty, P.C., Cox, N.J., Couch, R.B., Compans, R.W., Chen, H., Capua, I., Brown, I.H., Bouvier, N.M., Barclay, W.S., Kawaoka, Y., García-Sastre, A., Fouchier, R.A.M., Science, 2013, 10.1126/science.1235140

Encephalitis associated with influenza B virus infection in 2 children and a review of the literature, Subbarao, K., Safranek, T., Holst, A., Drake, C., Varman, M., Romero, J.R., Newland, J.G., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003

Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice, Ambrosino, D.M., Sullivan, J.L., Luzuriaga, K., Somasundaran, M., Vogel, L., Subbarao, K., Finberg, R.W., Lowy, I., Srinivasan, M., Graziano, R.F., Coccia, J.A., Thomas Jr., W.D., Hernandez, H.J., Roberts, A., Babcock, G.J., Greenough, T.C., Journal of Infectious Diseases, 2005, 10.1086/427242

Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4⁺ T Cells are important in control of SARS-CoV infection, Subbarao, K., Zaki, S.R., Bartlett, J.H., Paddock, C.D., Lamirande, E.W., Lau, Y.F., Chen, J., Journal of Virology, 2010, 10.1128/JVI.01281-09

A single-amino-acid substitution in a polymerase protein of an H5N1 influenza virus is associated with systemic infection and impaired T-cell activation in mice, Subbarao, K., Katze, M.G., Proll, S., Cheng, L.I., Ward, J.M., Carter, V., Santos, C., Gillim-Ross, L., Fornek, J.L., Journal of Virology, 2009, 10.1128/JVI.00994-09

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection, Wilson, P.C., Ahmed, R., Compans, R., Mulligan, M.J., Marasco, W.A., Subbarao, K., Yewdell, J.W., O'Donnell, C.D., Ranjan Das, S., Wang, Y., Rao Amara, R., Andrews, S., Kaur, K., Ali, Z., Huang, M., Lee, J.-H., Zheng, N.-Y., Del Rio, C., Razavi, B., Mehta, A., Lipkin, W.I., Hornig, M., Skountzou, I., McCausland, M., Morrissey, M., Sui, J., Edupuganti, S., Li, G.-M., Koutsonanos, D., Wrammert, J., Journal of Experimental Medicine, 2011, 10.1084/jem.20101352

Vaccination with DNA encoding internal proteins of influenza virus does not require CD8⁺ cytotoxic T lymphocytes: Either CD4⁺ or CD8⁺ T cells can promote survival and recovery after challenge, Subbarao, K., Bennink, J., Mostowski, H., Lo, C.-Y., Misplon, J.A., Stack, A., Epstein, S.L., International Immunology, 2000

Activation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in mice, Subbarao, K., Ooi, E.-E., Tang, L.-H., Lau, Y.-F., Virology, 2010, 10.1016/j.virol.2010.07.008

Influenza a infections: From chickens to humans, Subbarao, K., Clinical Microbiology Newsletter, 2001, 10.1016/S0196-4399(01)89051-6

Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys, Subbarao, K., Murphy, B., St. Claire, M., Zaki, S., Butler, E., Shieh, W.-J., Fischer, S., Fahle, G., Roberts, A., Vogel, L., McAuliffe, J., Virology, 2004, 10.1016/j.virol.2004.09.030

Predicting the evolution of human influenza A, Cox, N.J., Subbarao, K., Bender, C.A., Bush, R.M., Fitch, W.M., Journal of Heredity, 2000

Evaluation of the attenuation, immunogenicity, and efficacy of a live virus vaccine generated by codon-pair bias de-optimization of the 2009 pandemic H1N1 influenza virus, in ferrets, Subbarao, K., Mueller, S., Wimmer, E., Anafu, A., Santos, C.P., Broadbent, A.J., Vaccine, 2016, 10.1016/j.vaccine.2015.11.054

Palmitylation of the influenza virus hemagglutinin (H3) is not essential for virus assembly or infectivity, Lamb, R.A., Murphy, B.R., Leser, G.P., Bagai, S., Subbarao, K., Jin, H., Journal of Virology, 1996

Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody, Skehel, J.J., Gamblin, S.J., Lanzavecchia, A., Subbarao, K., Temperton, N.J., Santos, C., Suguitan, A.L., Monne, I., Collins, P.J., Walker, P.A., Lin, Y.P., Martin, S.R., Calder, L.J., Foglierini, M., Pinna, D., Liu, J., Corti, D., Xiong, X., Proceedings of the National Academy of Sciences of the United States of America, 2015, 10.1073/pnas.1510816112

Performance of rapid tests for detection of avian influenza A virus types H5N1 and H9N2 [3], Subbarao, K., McAuliffe, J.M., Nelson, N.A., Fedorko, D.P., Journal of Clinical Microbiology, 2006, 10.1128/JCM.44.4.1596-1597.2006

Live attenuated vaccines for pandemic influenza, Subbarao, K., Chen, G.L., Current Topics in Microbiology and Immunology, 2009, 10.1007/978-3-540-92165-3-5

The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus, Subbarao, K., Kemble, G., Swayne, D.E., Jin, H., Donis, R.O., Matsuoka, Y., Chen, L.-M., Desai, P.D., Marino, M.P., Suguitan Jr., A.L., Virology, 2009, 10.1016/j.virol.2009.09.017

Vaccines, Subbarao, K., Severe Acute Respiratory Syndrome, 2008, 10.1002/9780470755952.ch21

Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model, Subbarao, K., Katz, J.M., Cox, N.J., Donis, R.O., Tumpey, T.M., Harun, S., Sedyaningsih, E.R., Mai, L.Q., Hien, N.T., Falćon, A., Ortin, J., Rowe, T., Chen, H., Matsuoka, Y., Chen, L.-M., Maines, T.R., Proceedings of the National Academy of Sciences of the United States of America, 2006, 10.1073/pnas.0605134103

Evaluation of candidate vaccine approaches for MERS-CoV, Graham, B.S., Kong, W.-P., Mascola, J.R., Subbarao, K., Kwong, P.D., Rao, S.S., Denison, M.R., Jahrling, P., Hensley, L., Mollura, D.J., Solomon, J., Bagci, U., Todd, J.P., Olinger, G., Johnson, J.C., Vogel, L., Freeman, M., Becker, M.M., Chen, X., Yang, Z.-Y., Kanekiyo, M., Yassine, H.M., Zhou, T., Lees, C.R., Leung, K., Zhang, Y., Modjarrad, K., Joyce, M.G., Shi, W., Wang, L., Nature Communications, 2015, 10.1038/ncomms8712

A single dose of an avian H3N8 influenza virus vaccine is highly immunogenic and efficacious against a recently emerged seal influenza virus in mice and ferrets, Subbarao, K., Jin, H., Treanor, J.J., Cheng, X., Zengel, J.R., Matsuoka, Y., Paskel, M., Baz, M., Journal of Virology, 2015, 10.1128/JVI.00280-15

A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets, Subbarao, K., Jin, H., Treanor, J.J., Cheng, X., Zengel, J., Matsuoka, Y., Paskel, M., Baz, M., Journal of Virology, 2015, 10.1128/JVI.02449-14

Erratum: Nucleotide sequence changes in the polymerase basic protein 2 gene of temperature-sensitive mutants of influenza A virus (Virology (506- 510)), Murphy, B.R., Subbarao, E.K., Lawson, C.M., Virology, 1993, 10.1006/viro.1993.1379

Severe acute respiratory syndrome coronavirus infection of Golden Syrian hamsters, Subbarao, K., Zaki, S., Murphy, B., Hayes, N., Guarner, J., Vogel, L., Roberts, A., Journal of Virology, 2005, 10.1128/JVI.79.1.503-511.2005

Découvrez nos professeurs et professeures!

Kanta Subbarao

Contribution à la recherche

Axe de recherche de l'Université Laval :

Santé et bien-être durables

Thématiques de recherche de la Faculté de médecine :

Immunologie-infectiologie

Domaines et intérêts de recherche du (de la) professeur(e) :

Maladies infectieuses et immunitaires

Microbiologie

Projets de recherche

Publications

Contribution à l'enseignement aux cycles supérieurs

Vice-décanat à la recherche et à l'innovation